AAKP Innovator Series: AstraZeneca, Kerry Cooper, Vice President, U.S. Medical Affairs, Renal Cardio

Sidhvi Nekkanti
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology; Cardiovascular, Renal & Metabolism; and Respiratory.
Read More

KIDNEY PATIENTS AND THE GW SCHOOL OF MEDICINE AND HEALTH SCIENCES HOST INAUGURAL GLOBAL SUMMIT FOCUSED ON INNOVATIONS IN KIDNEY CARE

David Scott
American Association of Kidney Patients and GW School of Medicine & Health Sciences Welcome Global Leaders to present on innovations in patient-centered kidney care FOR IMMEDIATE RELEASE:April 8, 2019 WASHINGTON, D.C. – The American Association of Kidney Patients (AAKP) and the George Washington University (GW)
Read More